Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
on the production and in vitro characterization of several enzymes in parallel (proteases and hydrolases). This research programme is part of an international effort to answer the call for the development of new
-
health particularly among high-risk and underserved populations. We conduct groundbreaking research that advances treatment, we educate tomorrow's physician/researchers, and we work with amazing partners
-
benefit from an individualized training approach, including access to world renowned interdisciplinary mentors, a goal-directed development plan, a top-ranked scientific environment, exceptional educational
-
screening strategies being evaluated in large-scale clinical trials. The fellow will work under the mentorship of Drs. Elizabeth O’Donnell, MD, and Catherine Marinac, PhD, who oversee a research program
-
approach is transdisciplinary, transformative, and co-creative. The RIFS awards the Klaus Töpfer Sustainability Fellowship as part of its Fellow Programme. Prof. Dr Klaus Töpfer was the Founding Director of
-
foundation in related fields who are eager to learn and contribute to our research program. Technical duties include but are not limited to: Lead independent research projects, including hypothesis development
-
fellow to join our translational research program in macrophage biology/immunology. Our team takes a systems approach—integrating multi-omics, network science, machine learning, and comprehensive in vitro
-
such as system usability, improved patient outcomes, and workflow optimization. Preference will be given to candidates who have completed a clinical informatics fellowship or similar advanced degree program
-
position in a new lab with dedicated startup and international funding. As such, the Fellow will have the opportunity to shape the direction of this cutting-edge program at University of Michigan Ann Arbor
-
backgrounds, and design programs to promote public health particularly among high-risk and underserved populations. We conduct groundbreaking research that advances treatment, we educate tomorrow's physician